Related Experiment Video
Updated: Jun 12, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Advancement in the Treatment of Recurrent Pericarditis: Exploring Innovative Therapeutic Options
Hammad S Chaudhry1, Dawood Shehzad1, Mustafa Shehzad1
1Internal Medicine Residency Program, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Abstract:
Acute pericarditis, the predominant pericardial disease, often lacks a clear etiology, with 15-30% of patients experiencing recurrence, rising to 20-50% in those with prior relapses. Autoimmune mechanisms significantly contribute to recurrence, with interleukin-1 identified as a pivotal inflammatory mediator. While NSAIDs, colchicine, and steroids remain staples for acute cases, the spotlight in recurrent pericarditis management has shifted toward immunosuppressive medications. Pericardiectomy serves as the ultimate resort. Notably, rilonacept emerges as a key player, specifically addressing cases resistant to colchicine and dependent on corticosteroids in recurrent pericarditis.
More Related Videos
08:31A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
Related Concept Videos
Myocarditis III: Medical Management
Pericarditis IV: Nursing Management
Pericarditis II: Clinical features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Pericarditis I: Introduction
Endocarditis III: Medical Management